Briefly, the N‐terminus of PTX3 was suggested to inhibit angiogenesis and tumour growth in fibroblast growth factor (FGF)‐dependent murine prostate cancer and melanoma by binding to fibroblast growth factors, including FGF2 and FGF8b.28, 29. Here, FGF2 is linked to prostate carcinoma.